Literature DB >> 15573275

Extended myectomy for hypertrophic obstructive cardiomyopathy after failure or contraindication of septal ablation or with combined surgical procedures.

H Dörge1, J D Schmitto, O J Liakopoulos, S Walther, F A Schöndube.   

Abstract

BACKGROUND: Surgical correction of hypertrophic obstructive cardiomyopathy in severely symptomatic patients has been proven to be effective over the long term. The introduction of catheter-based procedures restricts surgical therapy to a subset of patients not suitable for septal ablation or requiring concomitant cardiac surgery.
METHODS: Between 8/2001 and 8/2003, 25 patients (58 +/- 15 years) underwent extended transaortic septal myectomy with partial excision and mobilization of the papillary muscles. Concomitant surgical procedures were performed in 40 % (CABG n = 9, aortic valve replacement n = 2). In 24 %, prior septal ablation was ineffective. Intraventricular gradient was 80 +/- 29 mm Hg at rest and 143 +/- 35 mm Hg during exercise. Mitral regurgitation affected 72 % of patients, and 88 % were NYHA functional class III or IV.
RESULTS: No hospital death, no postsurgical ventricular septal defect, and no complete atrioventricular block occurred. Severe nonfatal complications occurred in 24 % of patients. Intensive care was necessary for 1.8 +/- 1.7 days; total hospital stay was 11.8 +/- 3.8 days. Early follow-up was complete in 100 % (15 +/- 6 months, total of 376 months) with no late deaths, no relevant mitral regurgitation, or intraventricular gradients. Functional status was markedly improved (NYHA class I 40 %, class II 56 %, class III 4 %).
CONCLUSIONS: Early results of extended surgical myectomy and reconstruction of the subvalvular mitral apparatus in hypertrophic obstructive cardiomyopathy remain excellent with respect to mortality, morbidity, and functional capacity even when restricting surgery to patients earlier supposed to be at high risk.

Entities:  

Mesh:

Year:  2004        PMID: 15573275     DOI: 10.1055/s-2004-830323

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

1.  Minimally Invasive Versus Full-Sternotomy Septal Myectomy for Hypertrophic Cardiomyopathy.

Authors:  Farah N Musharbash; Matthew R Schill; Vivek H Hansalia; Richard B Schuessler; Jeremy E Leidenfrost; Spencer J Melby; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2018 Jul/Aug

2.  A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China.

Authors:  Shuiyun Wang; Mingyao Luo; Hongtao Sun; Yunhu Song; Chaohua Yin; Liqing Wang; Rutai Hui; Shengshou Hu
Journal:  Eur J Cardiothorac Surg       Date:  2012-07-03       Impact factor: 4.191

3.  Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy.

Authors:  Yongqiang Lai; Hongchang Guo; Jinhua Li; Jiang Dai; Changwei Ren; Yang Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

4.  Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy.

Authors:  Hong-Chang Guo; Jin-Hua Li; Teng-Yong Jiang; Chang-Wei Ren; Jiang Dai; Yu-Jie Zhou; Yong-Qiang Lai
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

5.  Comparison of Modified With Classic Morrow Septal Myectomy in Treating Hypertrophic Obstructive Cardiomyopathy.

Authors:  Bangrong Song; Ran Dong
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.